Bikdeli, B., Caraballo, C., Welsh, J., Ross, J. S., Kaul, S., Stone, G. W., & Krumholz, H. M. (2020). Non-inferiority Trials Using a Surrogate Marker as a Primary Endpoint: An Increasing Phenotype in Cardiovascular Trials. Clin Trials.
Styl ChicagoBikdeli, Behnood, César Caraballo, John Welsh, Joseph S. Ross, Sanjay Kaul, Gregg W. Stone, a Harlan M. Krumholz. "Non-inferiority Trials Using a Surrogate Marker As a Primary Endpoint: An Increasing Phenotype in Cardiovascular Trials." Clin Trials 2020.
Citace podle MLABikdeli, Behnood, et al. "Non-inferiority Trials Using a Surrogate Marker As a Primary Endpoint: An Increasing Phenotype in Cardiovascular Trials." Clin Trials 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..